Clearmind Medicine Files Three Provisional Patent Applications With USPTO

The applications for novel psychedelic-based combinations, developed with SciSparc, are based on monotherapy and novel combinations of SciSparc's Cannamide™ and classical psychedelics

byBill Haddad

February 15, 2023

1 minute read

The applications for novel psychedelic-based combinations, developed with SciSparc, are based on monotherapy and novel combinations of SciSparc’s Cannamide™ and classical psychedelics

Nissan Recalls SUVs Over Hood Opening Issue: Reuters

By Shivani Kumaresan

Today, 3:45 AM

Nissan Motor Co Ltd (OTC:NSANY) is recalling more than 300,000 of its Sports Utility Vehicles in the U.S. on…

NSANY

SELLAS Reports Updated Clinical Data From Phase 1/2 Study Of Galinpepimut-S Combined With Keytruda Showing 100% Of Patients Alive And 45.5 Percent Continuing Investigational Therapy As Of The Latest Follow-Up

By Bill Haddad

Today, 3:45 AM

Updated Data Shows 100 Percent of Patients Alive and 45.5 Percent Continuing Investigational Therapy as of the Latest Follow-Up Immune Data Shows GPS Induced WT1-Specific Immune

SLS

General

Chevron And Gevo Announce Intent To Pursue Sustainable Aviation Fuel Investment

By Bill Haddad

Today, 3:45 AM

Chevron U.S.A. Inc., a subsidiary of Chevron Corporation (NYSE:CVX), and Gevo, Inc. (NASDAQ:GEVO) today announced a letter of intent to jointly invest in building and operating one or more new facilities that would

CVX

Supreme Court Blocks Biden Extension Of Eviction Moratorium

By Phil Hall

Today, 3:45 AM

The U.S. Supreme Court has struck down the Biden administration’s efforts to extend the federal moratorium on the eviction of rental tenants that was enacted in 2020 at the height of the COVID-19 pandemic.

SPY

Clearmind Medicine Files Three Provisional Patent Applications With USPTO

Related Posts

Nissan Recalls SUVs Over Hood Opening Issue: Reuters

SELLAS Reports Updated Clinical Data From Phase 1/2 Study Of Galinpepimut-S Combined With Keytruda Showing 100% Of Patients Alive And 45.5 Percent Continuing Investigational Therapy As Of The Latest Follow-Up

Chevron And Gevo Announce Intent To Pursue Sustainable Aviation Fuel Investment

Supreme Court Blocks Biden Extension Of Eviction Moratorium